Patents by Inventor Kathleen Gilbert

Kathleen Gilbert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FLEXIBLE MICROELECTRONICS ADHESIVE
    Publication number: 20100219526
    Abstract: A curable thermal interface material is provided comprising a functionalized elastomer and a filler. Preferred materials comprise an epoxidized polybutadiene cured with an iodonium catalyst and a filler comprising silver and/or aluminum oxide.
    Type: Application
    Filed: May 7, 2010
    Publication date: September 2, 2010
    Inventors: RUSSELL STAPLETON, Robert Kyles, David Zoba, Kathleen Gilbert, Sara N. Paisner
  • FLEXIBLE MICROELECTRONICS ADHESIVE
    Publication number: 20080063873
    Abstract: A curable thermal interface material is provided comprising a functionalized elastomer and a filler. Preferred materials comprise an epoxidized polybutadiene cured with an iodonium catalyst and a filler comprising silver and/or aluminum oxide.
    Type: Application
    Filed: September 6, 2007
    Publication date: March 13, 2008
    Inventors: RUSSELL STAPLETON, Robert Kyles, David Zoba, Kathleen Gilbert, Sara N. Paisner
  • Derivatives of butyric acid and uses thereof
    Patent number: 7034020
    Abstract: The present invention provides a series of compounds having structural formulas wherein n1 is 1 to 5, n2 is 1 to 4 and m is 1 to 3; X is O or NH; Y is CH2, O, S, NH, NR; R is selected from the group consisting a straight-chain aliphatic group, a branched-chain aliphatic group and an alicyclic group; wherein R? is selected from the group consisting of hydrogen, methyl and ethyl; when Y is O, n1 is not 1; and wherein X and R? are independently optionally substituted at C2, C3 or C4 in compounds of Fomula IV or a pharmaceutically acceptable salt thereof. Also provided is a method of inactivating antigen-specific T cells in a n individual.
    Type: Grant
    Filed: December 12, 2003
    Date of Patent: April 25, 2006
    Assignee: The University of Arkansas for Medical Science
    Inventors: Kathleen Gilbert, E. Kim Fifer
  • Derivatives of butyric acid and uses thereof
    Publication number: 20040127564
    Abstract: The present invention provides a series of compounds having structural formulas 1
    Type: Application
    Filed: December 12, 2003
    Publication date: July 1, 2004
    Applicant: The University of Arkansas for Medical Sciences
    Inventors: Kathleen Gilbert, E. Kim Fifer
  • Derivatives of butyric acid
    Patent number: 6664394
    Abstract: The present invention provides a series of compounds having structural formulas wherein n1 is 1 to 5, n2 is 1 to 4 and m is 1 to 3; X is O or NH; Y is CH2, O, S, NH, NR; R is selected from the group consisting a straight-chain aliphatic group, a branched-chain aliphatic group and an alicyclic group; wherein R′ is selected from the group consisting of hydrogen, methyl and ethyl; when Y is O, n1 is not 1; and wherein X and R′ are independently optionally substituted at C2, C3 or C4 in compounds of Fomula IV or a pharmaceutically acceptable salt thereof. Also provided is a method of inactivating antigen-specific T cells in an individual.
    Type: Grant
    Filed: April 12, 2002
    Date of Patent: December 16, 2003
    Assignee: The Board of Trustees of the University of Arkansas
    Inventors: Kathleen Gilbert, E. Kim Fifer
  • Derivatives of butyric acid and uses thereof
    Publication number: 20020143056
    Abstract: The present invention provides a series of compounds having structural formulas 1
    Type: Application
    Filed: April 12, 2002
    Publication date: October 3, 2002
    Applicant: The University of Arkansas for Medical Sciences
    Inventors: Kathleen Gilbert, E. Kim Fifer
  • Derivatives of butyric acid and uses thereof
    Patent number: 6407107
    Abstract: The present invention provides a series of compounds having structural formulas wherein n1 is 1 to 5, n2 is 1 to 4 and m is 1 to 3; X is O or NH; Y is CH2, O, S, NH, NR; R is selected from the group consisting a straight-chain aliphatic group, a branched-chain aliphatic group and an alicyclic group; wherein R′ is selected from the group consisting of hydrogen, methyl and ethyl; when Y is O, n1 is not 1; and wherein X and R′ are independently optionally substituted at C2, C3 or C4 in compounds of Fomula IV or a pharmaceutically acceptable salt thereof. Also provided is a method of inactivating antigen-specific T cells in an individual.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: June 18, 2002
    Assignee: The Board of Trustees of the Unversity of Arkansas
    Inventors: Kathleen Gilbert, E. Kim Fifer